Regulation of [Ca(2+)](i) homeostasis in MRP1 overexpressing cells

FEBS Lett. 2000 May 26;474(1):107-10. doi: 10.1016/s0014-5793(00)01585-4.

Abstract

Regulation of capacitative Ca(2+) entry was studied in two different multidrug resistance (MDR) protein (MRP1) overexpressing cell lines, HT29(col) and GLC4/ADR. MRP1 overexpression was accompanied by a decreased response to thapsigargin. Moreover, inhibition of capacitative Ca(2+) entry by D, L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) was abolished in MRP1 overexpressing cells. Both PDMP and the MRP1 inhibitor MK571 greatly reduced InsP(3)-mediated (45)Ca(2+) release from intracellular stores in HT29 cells. Again, these effects were virtually abolished in HT29(col) cells. Our results point to a modulatory role of MRP1 on intracellular calcium concentration ([Ca(2+)](i)) homeostasis which may contribute to the MDR phenotype.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP-Binding Cassette Transporters / antagonists & inhibitors
  • ATP-Binding Cassette Transporters / genetics*
  • Adenocarcinoma
  • Calcium / metabolism*
  • Calcium Radioisotopes
  • Colonic Neoplasms
  • Gene Expression*
  • Homeostasis*
  • Humans
  • Inositol 1,4,5-Trisphosphate / pharmacology
  • Morpholines / pharmacology
  • Multidrug Resistance-Associated Proteins
  • Propionates / pharmacology
  • Quinolines / pharmacology
  • Thapsigargin / pharmacology
  • Tumor Cells, Cultured

Substances

  • ATP-Binding Cassette Transporters
  • Calcium Radioisotopes
  • Morpholines
  • Multidrug Resistance-Associated Proteins
  • Propionates
  • Quinolines
  • verlukast
  • Thapsigargin
  • RV 538
  • Inositol 1,4,5-Trisphosphate
  • Calcium